516535
GSK2606414
≥99% (HPLC), powder, PERK inhibitor, Calbiochem®
别名:
PERK抑制剂I，GSK2606414
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C24H20F3N5O
化学文摘社编号:
分子量:
451.44
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
PERK抑制剂I，GSK2606414, GSK2606414 is a cell-permeable, highly potent inhibitor of EIF2AK3/PERK (IC50 = 0.4 nM; [ATP] = 5 µM). Targets PERK in its inactive DFG conformation at the ATP-binding region.
SMILES string
O=C(CC1=CC=CC(C(F)(F)F)=C1)N2CCC3=C2C=CC(C4=CN(C)C5=C4C(N)=NC=N5)=C3
InChI
1S/C24H19F4N5O/c1-32-11-18(21-22(29)30-12-31-23(21)32)14-2-3-19-15(9-14)4-5-33(19)20(34)8-13-6-16(24(26,27)28)10-17(25)7-13/h2-3,6-7,9-12H,4-5,8H2,1H3,(H2,29,30,31)
InChI key
PXVQGBJMIQCDEX-UHFFFAOYSA-N
assay
≥99% (HPLC)
form
powder
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
protect from light
color
white
solubility
DMSO: 100 mg/mL
shipped in
ambient
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
主靶
Perk
Perk
可逆性：是
细胞可渗透性：具有
靶标IC50：针对 EIF2AK3/PERK 催化的 EIF2&α 的值为 0.4 nM
Disclaimer
毒性：标准处理（A）
General description
一种细胞可透过性的吡咯并嘧啶胺化合物，通过靶向PERK非活性DFG 构象的ATP结合区，发挥高效的EIF2AK3/PERK抑制剂作用 (IC50 = 0.4 nM; [ATP] = 5 µM)。相较对c-Kit、Aurora B、BRK、HRI/EIF2AK1、MLK2/MAP3K10、c-MER、DDR2、PKR/EIF2AK2和MLCK2/MYLK2的作用（IC50分别为 154、407、412、420、452、474、524、696和701 nM），选择性≥385倍。对280多种其它激酶几乎没有活性(IC50 >1 µM)。已证明在A549培养物中配合毒胡萝卜素可体内抑制ER应激-诱导PERK自磷酸化（100%，≤30 nM；60 min预孵育）。并可体内有效抑制小鼠PxBC-3肿瘤生长（50和150 mg/kg/12 h p.o.）。也可以提供25 mM的DMSO溶液（目录号508340）。
Other Notes
Packaging
用惰性气体包装
Preparation Note
溶解后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存至多6个月。
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Liliana Matos et al.
The journals of gerontology. Series A, Biological sciences and medical sciences, 70(8), 924-935 (2014-08-26)
The aging process is characterized by progressive accumulation of damaged biomolecules in the endoplasmic reticulum, as result of increased oxidative stress accompanying cellular senescence. In agreement, we hypothesized that WI-38 human cellular models of replicative senescence and stress-induced premature senescence
Daniel R Sandoval et al.
bioRxiv : the preprint server for biology (2021-04-02)
We identify the prolyl-tRNA synthetase (PRS) inhibitor halofuginone 1 , a compound in clinical trials for anti-fibrotic and anti-inflammatory applications 2 , as a potent inhibitor of SARS-CoV-2 infection and replication. The interaction of SARS-CoV-2 spike protein with cell surface
Bibha Dahal et al.
Virology, 539, 121-128 (2019-11-17)
Venezuelan equine encephalitis virus (VEEV) is a neurotropic virus that causes significant disease in both humans and equines. Here we characterized the impact of VEEV on signaling pathways regulating cell death in human primary astrocytes. VEEV productively infected primary astrocytes
Peter van Galen et al.
Nature, 510(7504), 268-272 (2014-04-30)
The blood system is sustained by a pool of haematopoietic stem cells (HSCs) that are long-lived due to their capacity for self-renewal. A consequence of longevity is exposure to stress stimuli including reactive oxygen species (ROS), nutrient fluctuation and DNA
Nirwana Fitriani Walenna et al.
The Journal of biological chemistry, 295(9), 2713-2723 (2020-01-30)
Fatty acid-binding protein 4 (FABP4) is predominantly expressed in adipocytes and macrophages and regulates metabolic and inflammatory pathways. FABP4 is secreted from adipocytes during lipolysis, and elevated circulating FABP4 levels are associated with obesity, metabolic disease, and cardiac dysfunction. We
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持